Emergency Physician Discretion to Activate the Cardiac Catheterization Team Decreases Door-to-Balloon Time for Acute ST-Elevation Myocardial Infarction

Annals of Emergency Medicine

Volumn 50, Issue 5, 2007, Pages 520-526

  Kraft, Phillip L ^a   Newman, Stacey ^a   Hanson, Danette ^a   Anderson, William ^a   Bastani, Aveh ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COMMUNITY HOSPITAL; EMERGENCY PHYSICIAN; FEMALE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION;

AGED; ELECTROCARDIOGRAPHY; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART CATHETERIZATION; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 35348959375     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.03.013     Document Type: Article

References (25)

1. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) 588-636
2. Grzybowski M., Clements E.A., Parsons L., et al. Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis. JAMA. 290 (2003) 1891-1898
3. Zijlstra F., de Boer M.J., Hoorntje J.C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328 (1993) 680-684
4. Zijlstra F., Beukema W.P., van't Hof A.W., et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 29 (1997) 908-912
5. ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update (for update of the 2001 PCI guidelines). J Am Coll Cardiol. 47 (2006) 216-235
6. Jacoby J., Axelband J., Patterson J., et al. Cardiac cath lab activation by the emergency physician without prior consultation decreases door-to-balloon time. J Invasive Cardiol. 17 (2005) 154-155
7. Cannon G.P., Gibson G.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 283 (2000) 2941-2947
8. Wiviott S.D., Morrow D.A., Giugliano R.P., et al. Performance of the Thrombolysis in Myocardial Infarction Risk Index for Early Acute Coronary Syndrome in the National Registry of Myocardial Infarction: a simple risk index predicts mortality in both ST and non-ST elevation myocardial infarction. J Am Coll Cardiol. 41 (2003) 365A [abstract]
9. De Luca G., Suryapranata H., Ottervanger J.P., et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225 Epub 2004 Mar. 8
10. Juliard J.M., Feldman L.J., Golmard J.L., et al. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-thrombolysis in myocardial infarction (TIMI) time. Am J Cardiol. 91 (2003) 1401-1405
11. Rogers W.J., Canto J.G., Lambrew C.T., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 36 (2000) 2056-2063
12. Goff D.C., Feldman H.A., McGovern P.G., et al., Rapid Early Action for Coronary Treatment (REACT) Study Group. Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT Trial. Am Heart J. 138 (1999) 1046-1057
13. Nallamothu B.K., and Bates E.R. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol. 92 (2003) 824-826
14. Williams D.O. Treatment delayed is treatment denied. Circulation 109 (2004) 1806-1808
15. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 355 (2006) 2308-2320 Epub 2006 Nov. 13
16. What is D2B? Available at: http://www.d2balliance.org/WhatisD2B/D2BCoreStrategies/tabid/145/Default.aspx. Accessed March 15, 2007.
17. Cannon C.P., Hand M.H., Bahr R., et al., National Heart Attack Alert Program (NHAAP) Coordinating Committee Critical Pathways Writing Group. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. Am Heart J. 143 (2002) 777-789
18. Mohanty S.A., Washington D.L., Lambe S., et al. Predictors of on-call specialist response times in California emergency departments. Acad Emerg Med. 13 (2006) 505-512
19. Fesmire F.M., Brady W.J., Hahn S., et al. Clinical policy: indications for reperfusion therapy in emergency department patients with suspected acute myocardial infarction. Ann Emerg Med. 48 (2006) 358-383
20. McCarthy B.D., Beshansky J.R., D'Agostino R.B., et al. Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med. 22 (1993) 579-582
21. Westdorp E.J., Gratton M.C., and Watson W.A. Emergency department interpretation of electrocardiograms. Ann Emerg Med. 21 (1992) 541-544
22. Todd K.H., Hoffman J.R., and Morgan M.T. Effect of cardiologist ECG review on emergency department practice. Ann Emerg Med. 27 (1996) 16-21
23. Kuhn M., Morgan M.T., and Hoffman J.R. Quality assurance in the emergency department: evaluation of the ECG review process. Ann Emerg Med. 21 (1992) 10-15
24. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
25. Bugiardini R., and Bairey Merz C.N. Angina with "normal" coronary arteries: a changing philosophy. JAMA 293 (2005) 477-484